Table 1.
Candidate | Platform | Developer | Approved Date |
---|---|---|---|
BNT162b2 | mRNA vaccine | Pfizer BioNTech | 31 December 2020 |
ChAdOx1-S (AZD1222) | Viral vector vaccine | Oxford/AstraZeneca | 16 February 2021 |
Ad26.COV 2.S | Viral vector vaccine | Johnson & Johnson | 12 March 2021 |
mRNA-1273 | mRNA vaccine | Moderna | 30 April 2021 |
BBIBP-CorV | Inactivated vaccine | Sinopharm | 7 May 2021 |
CoronaVac | Inactivated vaccine | Sinovac | 1 June 2021 |
BBV152 COVAXIN | Inactivated vaccine | Bharat Biotech | 3 November 2021 |
NVX-CoV2373 | Recombinant subunit vaccine | Novavax | 17 December 2021 |